← Product Code [IYX](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYX) · K023373 # ONEPASS NUCLEAR IMAGING SYSTEM, MODEL 70-500101 (K023373) _Gvi Technology Partners · IYX · Jan 3, 2003 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYX/K023373 ## Device Facts - **Applicant:** Gvi Technology Partners - **Product Code:** [IYX](/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYX.md) - **Decision Date:** Jan 3, 2003 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.1100 - **Device Class:** Class 1 - **Review Panel:** Radiology ## Indications for Use The OnePass nuclear medicine imaging system is intended for use as a diagnostic imaging device. Used with appropriate radiopharmaceuticals, it produces images that depict the anatomical distribution of radioisotopes within the human body. The OnePass system's compact footprint and small FOV detector are specifically designed for placement in a facility lacking adequate floor space for a typical nuclear medicine imaging system. The OnePass system's design is optimized for acquiring and processing cardiac first pass data. First-pass radionuclide angiography (FPRNA) is used to assess left and right ventricular function at rest or during stress. ## Device Story OnePass Nuclear Medicine Imaging System acquires/processes gated First Pass Radionuclide Angiography (FPRNA) images. System comprises single small field-of-view (FOV) detector on articulating arm; vertical lift mechanism tracks treadmill incline to maintain detector positioning over patient heart during stress testing. Used in clinical facilities with limited space. Physician uses qualitative/quantitative outputs to assess left/right ventricular function. Benefits include compact footprint for space-constrained environments and optimized cardiac assessment workflow. ## Technological Characteristics Single small field-of-view (FOV) scintillation gamma camera detector; articulating arm with vertical lift for treadmill tracking; optimized for cardiac FPRNA; standalone imaging system. ## Regulatory Identification A scintillation (gamma) camera is a device intended to image the distribution of radionuclides in the body by means of a photon radiation detector. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories. ## Predicate Devices - SIM-400 System, Scinticor, Inc. ([K931193](/device/K931193.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ #### 510(k) Summary of Safety and Effectiveness D Image /page/0/Picture/3 description: The image shows the logo for "GI Medical Devices". The logo consists of a stylized "GI" in a bold, black font. To the right of the "GI" is the text "MEDICAL DEVICES", also in a bold, black font. The logo is simple and professional, and it is likely used to represent a company that manufactures or distributes medical devices. Date Prepared Contact: Fax: E-mail: Telephone: Registration Number: Device Name and Classification CDRH Product Code: Classification Panel: Proprietary Name: Regulatory Device Class: 21 CFR Number: 1-October-2002 Establishment Name and Registration Number Manufacturer Name and Address: GVI Medical Devices 1470 Enterprise Parkway Twinsburg, Ohio 44087 Kevin Murrock 330-963-4083 330-963-4084 mailto:kevin.murrock@gvitp.com None 892.1100 90 IYX -Radiology OnePass Nuclear Imaging System Gamma Camera System Camera, Scintillation (Gamma) Common Name: Classification Name: Reason for 510(k) Submission New Device # Predicate Device SIM-400 System, Scinticor, Inc. 510(k) Number: K931193 #### Device Description The OnePass Nuclear Medicine Imaging Systems acquires and processes gated First Pass Radionuclide Angiography (FPRNA) images. After completion of acquisition, both qualitative and quantitative results are available to the physician for analysis. The acquisition system consists of a single small field-of-view detector mounted on an articulating arm to allow precise positioning of the detector over the patient's heart. In addition, a vertical lift adjusts the detector height position to track changes in the incline of the treadmill to ensure camera remains positioned directly over the patient's heart during acquisition. K623373 1470 Enterprise Parkway Twinsburg, Ohio 44087 Phone: (330) 963-4083 Fax: (330) 963-4084 JAN 0 3 2003 {1}------------------------------------------------ # Intended Use The OnePass nuclear medicine imaging system is intended for use as a diagnostic imaging device. Used with appropriate radiopharmaceuticals, it produces images that depict the anatomical distribution of radioisotopes within the human body. The OnePass system's compact footprint and small FOV detector are specifically designed for placement in a facility lacking adequate floor space for a typical nuclear medicine imaging system. The OnePass system's design is optimized for acquiring and processing cardiac first pass data. First-pass radionuclide angiography (FPRNA) is used to assess left and right ventricular function at rest or during stress. # Substantial Equivalence The OnePass is of a comparable type and substantially equivalent to the Scinticor SIM-400 System (510(k) Number K931193). Both devices are used to perform First-Pass Radionuclide Angiography (FPRNA) studies and contain similar performance characteristics. The primary difference between the devices is that the OnePass is optimized for performing only FPRNA studies, while the SIM-400 is capable of performing additional study types such as cardiac SPECT. # Conclusion The OnePass does not result in any new potential safety risks and performs as well as the SIM-400 for performing FPRNA studies. {2}------------------------------------------------ #### DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service 00 Corporate Boulevard ockville MD. 20850 JAN 03 2003 Mr. Kevin M. Murrock GVI Medical Devices 1470 Enterprise Parkway TWINSBURG OH 44087 Re: K023373 Trade/Device Name: OnePass Nuclear Medicine Imaging System Regulation Number: 21 CFR 892:1100 Regulation Name: Scintillation (gamma) camera Regulatory Class: I Product Code: 90 IYX Dated: October 1, 2002 Received: October 8, 2002 Dear Mr. Murrock: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed . predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: | 8xx.1xxx | (301) 594-4591 | |----------------------------------|----------------| | 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 | | 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 | | 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 | | Other | (301) 594-4692 | Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html. Sincerely yours, Nancy C. Brogdon Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ OnePass Nuclear Medicine Imaging System Section C. Indications for Use Statement #### Indications for Use Statement C 510(k) Number (if known): Device Name: OnePass Nuclear Medicine Imaging System Indications for Use: The OnePass nuclear medicine imaging system is intended for use as a diagnostic imaging device. Used with appropriate radiopharmaceuticals, it produces images that depict the : anatomical distribution of radioisotopes within the human body. The OnePass system's compact footprint and small FOV detector are specifically designed for placement in a facility lacking adequate floor space for a typical nuclear medicine imaging system. The OnePass system's design is optimized for acquiring and processing cardiac first pass data. First-pass radionuclide angiography (FPRNA) is used to assess left and right ventricular function at rest or during stress. #### PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED #### Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use (Per 21 CFR 801-109) OR Over-The-Counter Use 510(k) Notificatio Nancy C. Brogdon (Division Sign-Off) Division of Fi-productive, Abdominal, and Radiological Devices 5 1 (k) Number --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYX/K023373](https://fda.innolitics.com/submissions/RA/subpart-b%E2%80%94diagnostic-devices/IYX/K023373) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com